Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cochlear Ltd

Healthcare AU COH

103.75AUD
0.86(0.84%)

Last update at 2026-06-12T06:10:00Z

Day Range

103.19107.00
LowHigh

52 Week Range

88.74313.28
LowHigh

Fundamentals

  • Previous Close 102.89
  • Market Cap6759.63M
  • Volume338461
  • P/E Ratio19.58
  • Dividend Yield4.18%
  • EBITDA562.00M
  • Revenue TTM2338.50M
  • Revenue Per Share TTM35.75
  • Gross Profit TTM 1701.60M
  • Diluted EPS TTM5.28

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 518.50M 484.80M 396.60M 393.80M 365.70M
Minority interest - - - - -
Net income 388.90M 356.80M 300.60M 289.10M 326.50M
Selling general administrative 207.90M 212.60M 203.90M 159.00M 112.20M
Selling and marketing expenses 732.00M 685.00M 606.50M 498.70M 444.10M
Gross profit 1727.90M 1673.50M 1448.10M 1237.30M 1087.40M
Reconciled depreciation 90.40M 84.90M 80.90M 73.00M 79.50M
Ebit 529.50M 494.60M 406.00M 402.40M 377.70M
Ebitda 619.90M 579.50M 486.90M 475.40M 457.20M
Depreciation and amortization 90.40M 84.90M 80.90M 73.00M 79.50M
Non operating income net other - - - - -
Operating income 406.10M 521.50M 406.30M 380.90M 340.50M
Other operating expenses 1937.00M 1821.60M 570.60M 426.30M 307.00M
Interest expense 11.00M 9.20M 9.40M 8.60M 12.00M
Tax provision 129.60M 128.00M 96.00M 104.70M 39.20M
Interest income 11.70M 19.00M 7.10M 2.40M 3.60M
Net interest income 0.70M 9.80M 7.10M -6.20000M -8.40000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 129.60M 128.00M 96.00M 104.70M 39.20M
Total revenue 2343.10M 2235.60M 1936.10M 1648.30M 1497.60M
Total operating expenses 1321.80M 1259.50M 1136.20M 941.40M 855.40M
Cost of revenue 615.20M 562.10M 488.00M 411.00M 410.20M
Total other income expense net 112.40M 9.80M -3.30000M 31.10M 62.60M
Discontinued operations - - - - -
Net income from continuing ops 388.90M 356.80M 300.60M 289.10M 326.50M
Net income applicable to common shares 388.90M 356.80M 300.60M 289.10M 326.50M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2825.00M 2745.10M 2568.70M 2465.10M 2438.20M
Intangible assets 222.20M 193.30M 188.00M 135.40M 135.50M
Earning assets - - - - -
Other current assets - 44.90M 57.00M 79.00M 108.00M
Total liab 874.70M 904.60M 819.90M 779.40M 736.50M
Total stockholder equity 1950.30M 1840.50M 1748.80M 1685.70M 1701.70M
Deferred long term liab - - - 33.00M 53.30M
Other current liab - 220.00M 206.80M 161.80M 124.90M
Common stock - 1204.20M 1250.30M 1276.60M 1276.60M
Capital stock 1176.00M 1204.20M 1250.30M 1276.60M 1276.60M
Retained earnings 777.30M 667.90M 555.40M 455.30M 367.20M
Other liab - - 79.30M 76.60M 101.60M
Good will 278.60M 257.70M 256.10M 257.10M 267.30M
Other assets - - 126.90M 220.30M 203.40M
Cash 275.70M 513.60M 555.50M 629.30M 609.60M
Cash and equivalents - - 555.50M 629.30M 609.60M
Total current liabilities 602.30M 631.50M 578.00M 527.60M 402.50M
Current deferred revenue - 66.70M 61.60M 54.70M 42.80M
Net debt - -269.90000M -353.70000M -375.40000M -345.30000M
Short term debt - 41.60M 39.20M 78.70M 31.90M
Short long term debt - - - 42.60M -
Short long term debt total - 243.70M 201.80M 253.90M 264.30M
Other stockholder equity - - -1805.70000M -1731.90000M -1631.70000M
Property plant equipment - - 447.20M 439.20M 428.50M
Total current assets 1416.80M 1452.10M 1361.50M 1327.00M 1230.00M
Long term investments 78.90M 83.40M 97.30M 119.10M 199.50M
Net tangible assets - - 1304.70M 1326.20M 1352.20M
Short term investments - - 90.80M 68.80M 27.30M
Net receivables 533.80M 502.00M 437.50M 348.50M 296.30M
Long term debt - - - 0.00000M 45.00M
Inventory 499.40M 391.60M 311.50M 270.20M 216.10M
Accounts payable 298.40M 303.20M 270.40M 232.40M 202.90M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -31.60000M -56.90000M -46.20000M 57.90M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 110.50M 193.30M 93.30M 71.20M 30.60M
Deferred long term asset charges - - - - -
Non current assets total 1408.20M 1293.00M 1207.20M 1138.10M 1208.20M
Capital lease obligations 235.70M 243.70M 201.80M 211.30M 219.30M
Long term debt total - - 162.60M 175.20M 232.40M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -115.20000M -105.70000M -125.70000M -61.70000M 346.60M
Change to liabilities - - 31.80M 89.80M 65.00M
Total cashflows from investing activities -115.20000M -105.70000M -125.70000M -138.90000M 274.00M
Net borrowings - - -72.70000M -25.60000M -421.90000M
Total cash from financing activities -366.90000M -323.80000M -310.40000M -220.70000M -495.10000M
Change to operating activities - - 31.90M 8.90M -108.90000M
Net income 388.90M 356.80M 300.60M 289.10M 323.80M
Change in cash -237.90000M -41.90000M -73.80000M 19.70M 44.60M
Begin period cash flow 513.60M 555.50M 629.30M 609.60M 565.00M
End period cash flow 275.70M 513.60M 555.50M 629.30M 609.60M
Total cash from operating activities 237.60M 388.80M 362.40M 376.50M 265.40M
Issuance of capital stock 0.10M 0.10M - 1.10M 2.40M
Depreciation - 84.90M 71.90M 64.50M 68.80M
Other cashflows from investing activities -40.20000M -27.40000M -29.80000M -61.70000M 346.60M
Dividends paid -278.20000M -245.70000M 197.40M 194.00M 75.60M
Change to inventory -107.80000M -80.10000M -41.30000M -54.10000M 7.70M
Change to account receivables -101.70000M -53.60000M -89.00000M -52.20000M -60.80000M
Sale purchase of stock -28.30000M -43.00000M -29.60000M -29.60000M 1.70M
Other cashflows from financing activities -60.50000M -2.80000M -42.10000M -25.60000M -20.50000M
Change to netincome - - 23.30M -7.60000M -43.60000M
Capital expenditures 102.60M 89.80M 95.90M 77.20M 72.60M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -267.20000M -74.60000M -130.30000M -106.30000M -53.10000M
Stock based compensation - - 15.90M 10.80M 8.10M
Other non cash items 504.80M 106.60M -10.10000M 22.90M -127.20000M
Free cash flow 135.00M 299.00M 266.50M 299.30M 192.80M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COH
Cochlear Ltd		 0.86 0.84% 103.75 19.58 19.53 2.93 3.46 2.89 11.98
4DX
4DMEDICAL Ltd		 0.05 1.38% 3.68 - - 371.78 37.59 373.87 -7.2899
AVR
Anteris Technologies Global Corp		 -0.38 2.81% 13.12 - - 709.95 3.21 347.31 -5.1986
PNV
Polynovo Ltd		 -0.045 4.46% 0.96 104.00 34.97 5.15 8.64 5.13 103.01
IMR
Imricor Medical Systems Inc		 0.07 4.17% 1.75 - - 2079.35 36.28 1379.63 -2.6027

Reports Covered

Stock Research & News

View All

Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.

Cochlear Ltd

1 University Avenue, Sydney, NSW, Australia, 2109

Key Executives

Name Title Year Born
Mr. Diggory William Howitt BE (Hons), MBA CEO, MD, Pres & Exec. Director 1967
Mr. Stuart Sayers Chief Financial Officer NA
Mr. Jan Janssen MSc Elec Eng Chief Technology Officer 1965
Mr. Anthony Bishop Pres of Asia Pacific & Latin America NA
Ms. Lisa Aubert Pres of North America NA
Mr. Richard Brook MBA Pres of EMEA NA
Mr. David Hackshall Chief Information Officer NA
Ms. Kristina Devon VP of Investor Relations NA
Ms. Jennifer Stevenson VP of Corp. Communications & Brand NA
Mr. Dean Phizacklea Sr. VP of Global Strategic Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.